GTBP · GT Biopharma, Inc.
$0.30
-0.02 (-5.20%)
At close · Aug 6
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2025, financial statements, raised substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$10.85M
Shares
36.06M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 46,866 | $0.39 | $18,278 |
| 2026-07-13 | 14,900 | $0.43 | $6,407 |
| 2026-07-10 | 14,900 | $0.45 | $6,705 |
| 2026-07-09 | 14,900 | $0.47 | $7,003 |
| 2026-07-08 | 14,900 | $0.46 | $6,854 |
| 2026-07-07 | 31,498 | $0.49 | $15,434 |
| 2026-07-06 | 15,213 | $0.47 | $7,150 |
| 2026-07-02 | 14,900 | $0.49 | $7,301 |
| 2026-07-01 | 14,900 | $0.49 | $7,301 |
| 2026-06-30 | 26,200 | $0.44 | $11,528 |
| 2026-06-29 | 14,900 | $0.43 | $6,407 |
| 2026-06-26 | 14,900 | $0.42 | $6,258 |
| 2026-06-25 | 31,054 | $0.46 | $14,285 |
| 2026-06-24 | 15,162 | $0.49 | $7,429 |
| 2026-06-23 | 14,900 | $0.49 | $7,301 |
| 2026-06-22 | 14,900 | $0.51 | $7,599 |
| 2026-06-18 | 14,900 | $0.46 | $6,854 |
| 2026-06-17 | 28,490 | $0.45 | $12,821 |
| 2026-06-16 | 14,922 | $0.47 | $7,013 |
| 2026-06-15 | 15,871 | $0.45 | $7,142 |
| 2026-06-12 | 14,900 | $0.44 | $6,556 |
| 2026-06-11 | 14,900 | $0.42 | $6,258 |
| 2026-06-10 | 9,900 | $0.42 | $4,158 |
| 2026-06-09 | 9,900 | $0.43 | $4,257 |
| 2026-06-08 | 9,900 | $0.44 | $4,356 |
| 2026-06-05 | 9,900 | $0.48 | $4,752 |
| 2026-06-04 | 9,900 | $0.44 | $4,356 |
| 2026-06-03 | 20,577 | $0.47 | $9,671 |
| 2026-06-02 | 20,577 | $0.44 | $9,054 |
| 2026-06-01 | 9,900 | $0.48 | $4,752 |
| 2026-05-29 | 9,900 | $0.45 | $4,455 |
| 2026-05-28 | 9,900 | $0.40 | $3,960 |
| 2026-05-27 | 9,900 | $0.39 | $3,861 |
| 2026-05-26 | 9,900 | $0.44 | $4,356 |
| 2026-05-22 | 9,900 | $0.43 | $4,257 |
| 2026-05-21 | 9,900 | $0.42 | $4,158 |
| 2026-05-20 | 9,900 | $0.43 | $4,257 |
| 2026-05-19 | 21,113 | $0.36 | $7,601 |
| 2026-05-18 | 9,900 | $0.39 | $3,861 |
| 2026-05-15 | 17,896 | $0.44 | $7,874 |
| 2026-05-14 | 10,000 | $0.31 | $3,100 |
| 2026-05-13 | 10,000 | $0.32 | $3,200 |
| 2026-05-12 | 10,000 | $0.34 | $3,400 |
| 2026-05-11 | 10,000 | $0.38 | $3,800 |
| 2026-05-08 | 10,000 | $0.39 | $3,900 |
| 2026-05-07 | 10,000 | $0.40 | $4,000 |
Showing 1–46 of 46 settlements
Key facts
CIK
109657
CUSIP
36254L308
13F (30d)
20 filings
20 filers
Visit website
Investor relations